The Definitive Guide to Milademetan
These trials confirmed clinically substantial pharmacokinetic interactions [7] characterized by a lessen in the clearance in the anticancer drug and for this reason elevated exposure. The interpretation of subsequent stage II and III clinical trials was intricate as it was not possible to administer a similar dose of chemotherapy within the presenc